A5012177654- Glaucoma and retinal disorders
- Retinal Imaging and Analysis
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
- Alzheimer's disease research and treatments
- Neurological Disorders and Treatments
- Cardiovascular Health and Disease Prevention
- Gastric Cancer Management and Outcomes
- Neurological Disease Mechanisms and Treatments
- Entrepreneurship Studies and Influences
- Higher Education and Employability
- Nitric Oxide and Endothelin Effects
- Global Cancer Incidence and Screening
- Dementia and Cognitive Impairment Research
- Antioxidant Activity and Oxidative Stress
- Traumatic Brain Injury and Neurovascular Disturbances
- Colorectal Cancer Screening and Detection
- Job Satisfaction and Organizational Behavior
- Acute Ischemic Stroke Management
- S100 Proteins and Annexins
- Optical Imaging and Spectroscopy Techniques
Nanjing Foreign Language School
2023
Nanyang Technological University
2022
Indiana University – Purdue University Indianapolis
2015-2021
Indiana University School of Medicine
2015-2021
Midwest Eye Institute
2019
Indiana University
2016
Abstract Purpose To investigate the effects of an antioxidant dietary supplement that includes Ginkgo biloba, on retinal and retrobulbar blood flow in patients with open‐angle glaucoma ( OAG ). Methods Forty‐five confirmed were enroled a randomized, double blinded, placebo‐controlled cross‐over study. Baseline postadministration measurements intraocular pressure (IOP), ocular perfusion (OPP), flow, capillary non‐invasively measured (ultrasound laser Doppler modalities, respectively) before...
Introduction: To investigate the effects of a lutein complex supplementation on ocular blood flow in healthy subjects. Materials and Methods: Sixteen female patients (mean age 36.8 ± 12.1 years) were enrolled this randomized, placebo-controlled, double-blinded, two-period crossover study. Subjects received daily an oral dose with synergistic phytochemicals (lutein (10 mg), ascorbic acid (500 tocopherols (364 carnosic (2.5 zeaxanthin (2 copper reducing pro-inflammatory mediators cytokines...
Alzheimer's disease (AD) is an extremely familiar form of the dementia. After age 65, likelihood developing increases significantly. However, because pathogenesis AD insufficiently clear, intervention and treatment at early stage particularly critical. Since 2011, biomarkers have officially become standard for diagnosing disease. Potential carry out a significant role in clinical, studies other areas. Although cerebrospinal fluid (CSF), also positron emission tomography (PET) are effectual...